Select Publications
Journal articles
2021, 'Recent evidence on the effect of treatment of metabolic acid on the progression of kidney disease', Current Opinion in Nephrology and Hypertension, 30, pp. 467 - 473, http://dx.doi.org/10.1097/MNH.0000000000000728
,2021, 'Editor's note', Internal Medicine Journal, 51, pp. 1368, http://dx.doi.org/10.1111/imj.15462
,2021, 'Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1420 - 1425, http://dx.doi.org/10.1111/dom.14351
,2021, 'Recent evidence on the effect of urate-lowering treatment on the progression of kidney disease', Current Opinion in Nephrology and Hypertension, 30, pp. 346 - 352, http://dx.doi.org/10.1097/MNH.0000000000000699
,2021, 'A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes', Kidney International Reports, 6, pp. 695 - 705, http://dx.doi.org/10.1016/j.ekir.2020.12.019
,2021, 'Dietary Phosphate Consumption in Australians With Stages 3b and 4 Chronic Kidney Disease', Journal of Renal Nutrition, 31, pp. 155 - 163, http://dx.doi.org/10.1053/j.jrn.2020.02.007
,2021, 'The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes', Diabetes, Obesity and Metabolism, 23, pp. 763 - 773, http://dx.doi.org/10.1111/dom.14281
,2021, 'Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS', Kidney International Reports, 6, pp. 313 - 324, http://dx.doi.org/10.1016/j.ekir.2020.11.021
,2021, 'Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials', The BMJ, 372, http://dx.doi.org/10.1136/bmj.m4573
,2021, 'POS-311 POLYPHARMACY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HIGH PROGRESSION RISK', Kidney International Reports, 6, pp. S134 - S134, http://dx.doi.org/10.1016/j.ekir.2021.03.327
,2020, 'A randomized trial on the effect of phosphate reduction on vascular end points in CKD (improve-CKD)', Journal of the American Society of Nephrology, 31, pp. 2653 - 2666, http://dx.doi.org/10.1681/ASN.2020040411
,2020, 'Assessment of dietary sodium intake using the scored salt questionnaire in autosomal dominant polycystic kidney disease', Nutrients, 12, pp. 1 - 14, http://dx.doi.org/10.3390/nu12113376
,2020, 'Effect of urate-lowering therapy on cardiovascular and kidney outcomes: A systematic review and meta-analysis', Clinical Journal of the American Society of Nephrology, 15, pp. 1576 - 1586, http://dx.doi.org/10.2215/CJN.05190420
,2020, 'Allopurinol and Chronic Kidney Disease. Reply', The New England journal of medicine, 383, pp. 1691 - 1692, http://dx.doi.org/10.1056/NEJMc2026125
,2020, 'Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants', American Journal of Kidney Diseases, 76, pp. 311 - 320, http://dx.doi.org/10.1053/j.ajkd.2020.02.446
,2020, 'Effects of allopurinol on the progression of chronic kidney disease', New England Journal of Medicine, 382, pp. 2504 - 2513, http://dx.doi.org/10.1056/NEJMoa1915833
,2020, 'Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial', American Journal of Nephrology, 51, pp. 201 - 215, http://dx.doi.org/10.1159/000505717
,2020, 'Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry', Peritoneal Dialysis International, 40, pp. 209 - 219, http://dx.doi.org/10.1177/0896860819894058
,2020, 'Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis', New England Journal of Medicine, 382, pp. 622 - 631, http://dx.doi.org/10.1056/nejmoa1803537
,2020, 'Crystalglobulinemia in Multiple Myeloma: A Rare Case Report of Survival and Renal Recovery', Canadian Journal of Kidney Health and Disease, 7, http://dx.doi.org/10.1177/2054358120922629
,2020, 'Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients', Peritoneal Dialysis International, 40, pp. 47 - 56, http://dx.doi.org/10.1177/0896860819879891
,2020, 'Sex Differences in CKD Prevalence in Asia: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 31, pp. 179 - 179, http://dx.doi.org/10.1681/asn.20203110s1179c
,2020, 'The Effects of Allopurinol on the Progression of CKD According to Baseline Kidney Function: Prespecified Analyses of the CKD-FIX Trial', Journal of the American Society of Nephrology, 31, pp. 228 - 229, http://dx.doi.org/10.1681/asn.20203110s1228d
,2020, 'The Effects of Allopurinol on the Progression of CKD According to Baseline Serum Urate Level: Results from Post Hoc Analyses of the CKD-FIX Trial', Journal of the American Society of Nephrology, 31, pp. 223 - 223, http://dx.doi.org/10.1681/asn.20203110s1223a
,2019, 'The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program', The Lancet Rheumatology, 1, pp. e220 - e228, http://dx.doi.org/10.1016/S2665-9913(19)30078-5
,2019, 'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicine, 171, pp. 181 - 189, http://dx.doi.org/10.7326/M19-0087
,2019, '1216-P: The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', Diabetes, 68, http://dx.doi.org/10.2337/db19-1216-p
,2019, 'Differences in peritoneal dialysis technique survival between patients treated with peritoneal dialysis systems from different companies', Nephrology Dialysis Transplantation, 34, pp. 1035 - 1044, http://dx.doi.org/10.1093/ndt/gfy340
,2019, 'Dual inhibition of gastrointestinal phosphate absorption: More questions than answers', Journal of the American Society of Nephrology, 30, pp. 909 - 910, http://dx.doi.org/10.1681/ASN.2019040333
,2019, 'Recent evidence for direct oral anticoagulants in chronic kidney disease', Current Opinion in Nephrology and Hypertension, 28, pp. 251 - 261, http://dx.doi.org/10.1097/MNH.0000000000000493
,2019, 'Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial', PLoS ONE, 14, http://dx.doi.org/10.1371/journal.pone.0213274
,2019, 'THE ASSOCIATION OF FUNCTIONAL STATUS WITH MORTALITY AND DIALYSIS MODALITY CHANGE: RESULTS FROM THE PERITONEAL DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (PDOPPS)', PERITONEAL DIALYSIS INTERNATIONAL, 39, pp. 103 - 111, http://dx.doi.org/10.3747/pdi.2018.00094
,2019, 'Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study', BMJ Open, 9, pp. e024382, http://dx.doi.org/10.1136/bmjopen-2018-024382
,2019, 'SAT-224 ESTIMATES OF DIETARY PHOSPHATE CONSUMPTION AND COMMON FOOD SOURCES OF PHOSPHATE IN AUSTRALIANS WITH CHRONIC KIDNEY DISEASE', Kidney International Reports, 4, pp. S100 - S100, http://dx.doi.org/10.1016/j.ekir.2019.05.259
,2019, 'SUN-292 BENEFITS AND HARMS OF VITAMIN D COMPOUNDS IN ADULTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', Kidney International Reports, 4, pp. S281 - S281, http://dx.doi.org/10.1016/j.ekir.2019.05.797
,2018, 'Urate-Lowering Therapy for Preventing Kidney Disease Progression: Are We There Yet?', American Journal of Kidney Diseases, 72, pp. 776 - 778, http://dx.doi.org/10.1053/j.ajkd.2018.07.022
,2018, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD007554.pub3
,2018, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD011798.pub2
,2018, 'Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study', American Journal of Kidney Diseases, 72, pp. 188 - 197, http://dx.doi.org/10.1053/j.ajkd.2017.10.019
,2018, 'Outcomes of acinetobacter peritonitis in peritoneal dialysis patients: A multicenter registry analysis', Peritoneal Dialysis International, 38, pp. 257 - 265, http://dx.doi.org/10.3747/pdi.2017.00199
,2018, 'Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry', American Journal of Kidney Diseases, 71, pp. 814 - 821, http://dx.doi.org/10.1053/j.ajkd.2017.10.017
,2018, 'FP468RISK PREDICTORS AND CAUSES OF TECHNIQUE FAILURE WITHIN THE FIRST YEAR OF PERITONEAL DIALYSIS', Nephrology Dialysis Transplantation, 33, pp. i194 - i194, http://dx.doi.org/10.1093/ndt/gfy104.fp468
,2018, 'The relationship between body mass index and organism-specific peritonitis', Peritoneal Dialysis International, 38, pp. 206 - 214, http://dx.doi.org/10.3747/pdi.2017.00188
,2018, 'Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)', BMJ Open, 8, pp. e018794, http://dx.doi.org/10.1136/bmjopen-2017-018794
,2017, 'Outcomes of corynebacterium peritonitis: A multicenter registry analysis', Peritoneal Dialysis International, 37, pp. 619 - 626, http://dx.doi.org/10.3747/pdi.2017.00028
,2017, 'Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, 22, pp. 823 - 824, http://dx.doi.org/10.1111/nep.12823
,2017, 'Breast Cancer and Transplantation', American Journal of Transplantation, 17, pp. 2243 - 2253, http://dx.doi.org/10.1111/ajt.14368
,2017, 'Representativeness of honeypot trial participants to Australasian PD patients', Peritoneal Dialysis International, 37, pp. 516 - 522, http://dx.doi.org/10.3747/pdi.2016.00065
,2017, 'TEMPORAL TRENDS IN CLINICAL OUTCOMES OF KIDNEY TRANSPLANTATION FROM 1996 TO 2013 IN AUSTRALIA AND NEW ZEALAND', NEPHROLOGY, 22, pp. 91 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408833200309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis', Clinical Journal of the American Society of Nephrology, 12, pp. 1090 - 1099, http://dx.doi.org/10.2215/CJN.12321216
,